Biopharma CEOs see soaring compensation, new analysis to be discussed live

Endpoints News released the first installment of its annual biopharma compensation project, breaking down the pay of the industry’s highest-earning CEOs.

The company will host a Post-Hoc Live webcast at 12:30 p.m. ET, where senior biopharma correspondent Andrew Dunn and executive editor Drew Armstrong will walk through the headline figures and explain how the data were gathered.

The analysis also compares executive pay to median employee salaries, highlights large severance packages and other perks, and asks whether biopharma firms could allocate those funds differently to support innovation and global competition.